Article
Presented by Martin G. Sanda, MD, University of Michigan, Ann Arbor.
Category I CPT code granted to irreversible electroporation for prostate lesions
Key updates from the AUA/ASRM male infertility guideline amendment
Sacituzumab govitecan withdrawn from bladder cancer market following negative trial
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Low-intensity shockwave therapy, plasma injections efficacious for erectile dysfunction
CCH appears safe, efficacious in Peyronie disease with ventral curvature